You are here

Program News and Releases

Patient Cells Yield Potential Therapies For Familial Dysautonomia

Lorenz Studer reports the first large-scale drug discovery screen based on an iPSC-derived disease model.

read more

Two NYSTEM-funded Scientists Elected as Fellows to AAAS

Drs. Shahin Rafii and Ming-Ming Zhou were elected as Fellows of the American Association for the Advancement of Science.

read more

The Ubiquitin-Proteasome System Adds Complexity to Pluripotency and Reprogramming

New data from Iannis Aifantis shows the Ubiquitin-Proteasome System functions in both reprogramming and differentiation of pluripotent stem cells, partially through targeting of c-Myc.

read more

Amniotic Fluid Cells Reprogrammed to Endothelial Cells

Shahin Rafii reports the efficient direct conversion of amniotic fluid-derived cells into functional vascular endothelial cells.

read more

Gene Therapy for α-Thalassemia in iPS Cells

Dr. Eric Bouhassira reports zinc finger nuclease-mediated gene correction for α-thalassemia in patient iPSCs.

read more

Molecular Mechanisms of Reprogramming Unveiled

New research from Dr. Asa Abeliovich provides insight to the molecular mechanisms of reprogramming.

read more

Identification of a Key Regulatory Factor in Hematopoiesis and Cancer

New data from Dr. Ulrich Steidl identifies a key transcription factor that regulates hematopoiesis and promotes acute myeloid leukemia.

read more

Novel Gene Sets Identified that Regulate the Survival of Leukemia Stem Cells

Leukemia stem cells (LSCs) represent a biologically distinct subpopulation of myeloid leukemias, with reduced cell cycle activity and increased resistance to therapeutic challenge.

read more

A New Method to Improve the Yield of RBCs Over 100-fold

Eric Bouhassira’s group defines a method to improve the yield of RBCs over 100-fold. RBCs are critical for blood transfusions in surgeries, trauma care, and blood diseases such as sickle cell disease. Dr. Bouhassira and colleagues at the Albert Einstein College of Medicine combined several different methodologies to increase the number of RBCs in a sample by over 100-fold, and can envisage significant further improvements.

read more

FDA Approves Trial of Stem Cell-Based Gene Therapy for Blood Disease

Dr. Michel Sadelain leads a team developing a potential cure for β-thalassemia.

read more


Subscribe to News Feed